2015年，中保投资通过股权投资方式支持招商局轮船境外项目，包括斯里兰卡科伦坡港、汉班托塔港、吉布提国际自由港等港口建设。从初期计划的400 亿元到如今累计合作规模的480亿元，充分彰显其作为保险行业的投资平台汇聚具有长期资本属性的保险资金的作用。 这些案例是中保投资服务实体经济、服务国家发展战略的一个缩影。贾飙表示，过去十年，中保投资在支持国家重大基础设施建设、服务城市更新、扶持 硬核科技企业发展、国企混改、辅助监管等方面积极探索，形成了具有自身特色的以"资产管理+投资"为两大核心业务的经营模式。站在新起点上，中保 投资将持续巩固提升四大核心竞争力。 一是卓越的品牌影响力。作为保险行业的投资平台，中保投资不仅拥有深厚的发展积淀，更在资产管理行业确立了广泛的市场号召力。 新华财经上海12月17日电（记者陈云富、王淑娟）2015年12月18日，中保投资有限责任公司（下称"中保投资"）在上海成立。作为"中字头"保险行业基金 ——中国保险投资基金的管理人和普通合伙人，十年砥砺前行，中保投资累计管理规模已超4500亿元，拥有丰富的"股+债+夹层"鲜明特点的丰富产品工 具箱，成为国内长期投资、耐心资本领域不容忽视的重要 ...

Core Insights - Shanghai United Imaging Healthcare Co., Ltd. has won a bid for a high-end CT procurement project in Wenshan Zhuang and Miao Autonomous Prefecture, with a contract amount of 10.8 million [1][2]. Company Overview - Shanghai United Imaging Healthcare Co., Ltd. has invested in 21 companies and participated in 8,581 bidding projects [1]. - The company holds 915 trademark registrations, 5,568 patents, and 109 copyrights, along with 457 administrative licenses [1]. Project Details - The procurement was announced by the Wenshan Zhuang and Miao Autonomous Prefecture Health Commission on December 15, 2025 [2]. - The project involves the procurement of a 256-slice ultra-high-end CT system [1].

Core Conclusions - The report highlights the potential impact of Japan's interest rate hike on global liquidity, suggesting that while there are concerns, the actual shock may be limited due to previous adjustments in the market [7][8][9] - The medical device and healthcare sectors are expected to rebound, driven by innovation and international expansion, despite current pressures from macroeconomic factors [2][14] - The energy storage industry is poised for growth, supported by favorable policies and increasing demand, with key players identified for investment [3][18][19] Group 1: Strategy and Market Outlook - The report suggests a continued positive outlook for AH shares, with strategic allocations in government bonds and gold, while US stocks and bonds may remain volatile [1][13] - Japan's potential interest rate hike is seen as a catalyst for global liquidity concerns, but the actual impact may be mitigated by prior market adjustments and the current economic environment [7][8][9] Group 2: Medical Device and Healthcare Sector - The medical device sector is currently undervalued, with significant potential for recovery driven by innovation and government support for healthcare services [2][14] - Key areas of focus include domestic device upgrades, international market expansion, and the recovery of hospital services, with specific recommendations for investment in leading companies [14][15][16] Group 3: Energy Storage Industry - The energy storage sector is experiencing robust growth, with a projected global installed capacity of 329 GWh by 2025, reflecting an 87% year-on-year increase [19] - Key recommendations include investing in leading battery manufacturers and energy storage system providers, as demand continues to outpace supply [20][19] Group 4: Real Estate Market Analysis - The real estate market is facing challenges, with a notable decline in sales volume and prices, indicating ongoing pressure in the sector [21][22] - The report anticipates a continued low-level fluctuation in the market, with potential policy adjustments expected after the Spring Festival [23]

Group 1: Medical Device Sector - The medical device sector is expected to benefit from policies promoting large-scale equipment updates and innovative devices, with a focus on domestic equipment replacement and bidding recovery [1] - The high-end medical equipment industry is projected to maintain high prosperity by 2025, with strong cost-performance ratios due to significant sector corrections from 2021 to 2024 [1] - Recommended stocks in the medical device sector include Mindray Medical (300760), United Imaging, Haitai New Light, and others, with a focus on segments like hemodialysis, ultrasound, endoscopy, and oral care [1] Group 2: Medical Consumption Sector - The government has introduced multiple policies to enhance grassroots medical service capabilities, aiming for improved accessibility to medical services by 2027 [2] - With the enhancement of medical insurance payments and increased public payment capacity, the medical consumption sector is expected to have significant growth potential [2] - Recommended stocks in the medical consumption sector include Gushengtang, with additional attention on Yingkang Life (300143) and Ruil Group [2] Group 3: Offline Pharmacy Sector - The offline pharmacy sector is currently experiencing low valuations due to a weak macroeconomic environment, with a significant number of pharmacies closing down, leading to increased market concentration [3] - National policies are supporting the diversified development of pharmacies, with leading pharmacies adapting their store formats and focusing on non-pharmaceutical products to drive growth [3] - Recommended stocks in the offline pharmacy sector include Yifeng Pharmacy (603939) and Daclin (603233), with additional focus on Laobaixing, Yixin Hall (002727), and others [3]

Core Viewpoint - The recent announcement by Moer Thread to manage idle fundraising of 7.5 billion yuan has attracted significant market attention, highlighting a trend among A-share companies, including those on the Sci-Tech Innovation Board, to utilize idle funds for cash management [1][2]. Group 1: Idle Fund Management in A-Share Market - Over the past three years, more than 110 A-share listed companies have reported annual idle cash management exceeding 5 billion yuan, including 14 companies from the Sci-Tech Innovation Board [1]. - Among the 12 Sci-Tech Innovation Board companies managing idle funds, 6 have amounts exceeding 5 billion yuan, with Moer Thread managing 7.5 billion yuan and Huahong managing 21 billion yuan [2]. Group 2: Regulatory Framework and Recent Changes - The China Securities Regulatory Commission (CSRC) has established regulations for the management of idle fundraising, which were revised and upgraded in June 2025 to enhance oversight [6][10]. - The latest regulations stipulate that idle funds can be managed through dedicated accounts, ensuring that cash management does not interfere with the normal investment plans of the fundraising [10]. Group 3: Industry Practices and Investor Concerns - Companies in the high-end computing sector often face long technical cycles, making the use of idle funds for cash management a common practice [4]. - There is a call from investors and industry insiders for more detailed disclosures regarding the management of idle funds to enhance transparency and protect investor interests [1][12].

Core Viewpoint - Zhongbao Investment has established itself as a significant player in the long-term investment and patient capital sector in China, managing over 450 billion yuan in assets and focusing on supporting national development strategies through a new strategic plan [2][4][8]. Group 1: Company Overview - Zhongbao Investment was founded in December 2015 in Shanghai and serves as the manager and general partner of the China Insurance Investment Fund [2]. - The company has developed a diverse product toolbox characterized by "equity + debt + mezzanine" investments, emphasizing its role in the domestic long-term investment landscape [2]. Group 2: Strategic Initiatives - In December 2024, Zhongbao Investment collaborated with Xinhua Insurance and Zhonghui Life to establish the Zhijixin Fund, investing approximately 2.037 billion yuan to acquire shares in the Shanghai Integrated Circuit Industry Investment Fund, marking the largest single S fund transaction in China that year [3]. - The company raised 20 billion yuan to invest in Shanghai Real Estate Group to support urban renewal projects, benefiting nearly 60,000 residents [3]. - Zhongbao Investment has supported major infrastructure projects and technology enterprises, with cumulative cooperation scale reaching 48 billion yuan in overseas port projects [3][4]. Group 3: Competitive Advantages - The company has established four core competitive advantages: 1. Strong brand influence in the asset management industry [4]. 2. Unique integration capabilities due to its regulatory background, acting as a bridge between government and market [4]. 3. Diverse product innovation, offering customized financial solutions across various sectors [4]. 4. Agile decision-making structure that enhances responsiveness to market changes [5]. Group 4: Investment Philosophy - Zhongbao Investment emphasizes the importance of long-term, rational, and value-based investments, avoiding short-term speculation [6]. - The company is actively investing in key sectors such as integrated circuits, renewable energy, and biomedicine, supporting leading technology firms to address critical challenges [6][7]. Group 5: Future Development Strategy - The company plans to implement a new strategic framework of "One Foundation, Two Industries, Three Comprehensives, and Four Transformations" to enhance its asset management capabilities and international presence [8]. - Zhongbao Investment aims to expand its international asset allocation to meet the growing demands of Chinese enterprises going global [8].

贾飙 ◎记者 何奎 累计管理规模已超4500亿元、陪伴中国"英伟达"们成长……十年栉风沐雨、砥砺前行，中保投资有限责 任公司（下称"中保投资"）作为"中字头"保险行业基金——中国保险投资基金的管理人和普通合伙人， 成立十年来，交出了一份亮眼的"成绩单"。 1 2015年，国务院同意中国保险投资基金设立方案；同年12月18日，中保投资在上海成立，并被赋予"服 务实体经济发展，促进经济提质增效升级"的使命。如今，中保投资拥有"股+债+夹层"特点鲜明的丰富 产品工具箱，是国内长期投资、耐心资本领域不容忽视的重要力量，也成为耐心资本服务国家战略的成 功典范。 近日，中保投资董事长、上海资产管理协会会长贾飙在接受上海证券报记者专访时表示，公司将继续坚 定以耐心资本服务实体经济发展的使命，未来将通过"一基、两业、三全、四化"的新战略规划实施，致 力于打造一流的综合性资产管理集团。 为国担当： 当好耐心资本服务新质生产力发展 12月5日，成立仅5年、号称"中国版英伟达"的摩尔线程在科创板上市，以114.28元/股的发行价、近80亿 元的募资总额，双双创下2025年科创板IPO之最，成为资本市场名副其实的"明星项目"。在摩尔 ...

智通财经APP获悉，东方财富证券发布研报称，随着中国创新药License-out项目总金额创下新纪录，临 床前项目占比持续保持高位，ADC、双/多抗、小核酸等新兴疗法，以及代谢领域中肥胖适应症等或为 未来License-out项目的重点方向。我国创新药企业已从高投入低产出的研发探索期过渡到了管线密集收 获期，与此同时商保的发展有望让原先的创新药"单一"支付向多元支付转型。此外，医疗器械2025年招 采端持续复苏，关注设备更新政策与资金落地持续驱动需求释放。 东方财富证券主要观点如下： 标的方面 创新药板块建议关注百济神州(06160)、恒瑞医药(01276)、中国生物制药(01177)、三生制药(01530)/三生 国健(688336.SH)、石药集团(01093)等。医疗器械板块：1）内需修复：建议关注迈瑞医疗(300760.SZ)、 联影医疗(688271.SH)、开立医疗(300633.SZ)、澳华内镜(688212.SH)等；2）出海兑现：建议关注海泰新 光(688677.SH)、新产业(300832.SZ)等；3）脑机接口：建议关注诚益通(300430.SZ)、伟思医疗 (688580.SH)等。 ...

Group 1 - The core announcement is that Shanghai United Imaging Healthcare Co., Ltd. has won the bid for the advanced medical equipment update project in Guangdong Province, specifically for the medical vascular angiography X-ray machine (DSA) [1][2] - The contract amount for the project is 8,560,000.0 [2] - The procurement is initiated by the Guangdong Provincial Health Commission [2] Group 2 - Shanghai United Imaging Healthcare Co., Ltd. has invested in 21 enterprises and participated in 8,581 bidding projects [1] - The company holds 915 trademark registrations, 5,568 patents, and 109 copyright registrations [1] - Additionally, the company possesses 457 administrative licenses [1]

Core Insights - The 2025 Hainan International Health Industry Expo will take place from December 19 to 22 in Sanya, aiming to create an internationally influential brand exhibition through investment platforms and expert discussions [2][4] Group 1: Exhibition Overview - The expo will cover an area of 12,000 square meters and feature five core exhibition areas: innovative pharmaceuticals and medical devices, high-end health care, rehabilitation therapy, traditional Chinese medicine, and health products [2][3] - Three special experience zones will be set up: sleep experience zone, music therapy experience zone, and black technology experience zone, showcasing the latest achievements in the health industry [2][3] Group 2: Exhibitors and Innovations - Notable exhibitors include United Imaging Healthcare showcasing interventional robots and complex surgical room models, and Mindray bringing advanced decision support systems and IoT management systems [3] - Huawei will present smart wearable devices, while other companies will display innovative products such as AI-assisted sleep solutions and traditional Chinese medicine-based nutritional supplements [3] Group 3: Forums and Activities - The expo will host multiple professional forums, including discussions on women's and children's health management, green medical development, and the integration of traditional medicine with modern nutrition [4] - The Boao International Health Forum and vocational skills competition will also be held concurrently, aimed at promoting standardized health technology and cultivating professionals in the health industry [4] Group 4: Community Engagement - A walking event will be organized to promote healthy lifestyles and enhance public health awareness, fostering a societal focus on health [5]